The Clorox Company (CLX) income statement
NYSE · Consumer Defensive · Household & Personal Products · 9,200 employees · CEO Linda J. Rendle
- Price
- $107.89
- Market cap
- $13.1B
- Enterprise value
- $18.5B Data as of 2026-11-12
- Last report
- Q1 '27 filed 2026-11-02
- Next report
- 2027-02-02 EPS est. $0.98
The Clorox Company (CLX) reported revenue of $1.91B for Q1 '27 (+33.3% year on year), operating income of $261M (13.7% of revenue) and net income of $170M. Over the last four quarters revenue was $7.2B.
Income statement
| Income statement | Trend | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.99B | $1.81B | $1.9B | $1.76B | $1.69B | $1.67B | $1.99B | $1.43B | $1.67B | $1.67B | $1.95B | $1.91B | |
| Cost of revenue | $1.12B | $1.05B | $1.02B | $955M | $948M | $924M | $1.06B | $833M | $951M | $948M | $1.14B | $1.14B | |
| Gross profit | $866M | $766M | $884M | $807M | $738M | $744M | $924M | $596M | $722M | $722M | $804M | $770M | |
| Research & development | $32M | $32M | $33M | $31M | $31M | $27M | $32M | $28M | $29M | $27M | $32M | $29M | |
| Sales & marketing | $186M | $215M | $266M | $201M | $191M | $207M | $171M | $166M | $190M | $177M | $0 | $190M | |
| General & administrative | $493M | $301M | $268M | $281M | $280M | $267M | $296M | $277M | $262M | $229M | $0 | $290M | |
| Other operating expenses | $7M | $7M | $29M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | -$15M | $0 | |
| Operating expenses | $718M | $555M | $596M | $519M | $507M | $506M | $504M | $476M | $486M | $438M | -$218M | $509M | |
| Operating income | $148M | $211M | $288M | $288M | $231M | $238M | $420M | $120M | $236M | $284M | $1.02B | $261M | |
| Interest income | $7M | $4M | $0 | $0 | $2M | $2M | $2M | $2M | $1M | $4M | $1M | $1M | |
| Interest expense | $26M | $22M | $21M | $21M | $22M | $23M | $22M | $23M | $25M | $27M | $55M | $52M | |
| Other non-operating income (gains on investments, FX ...) | -$14M | $231M | -$8M | $90M | -$28M | -$39M | -$12M | -$10M | -$4M | $1M | $754M | $2M | |
| Total non-operating income | -$12M | -$253M | -$13M | -$111M | $6M | $16M | -$10M | -$13M | -$21M | -$28M | -$809M | -$54M | |
| Income before tax | $136M | -$42M | $275M | $177M | $237M | $254M | $410M | $107M | $215M | $256M | $213M | $207M | |
| Income tax | $40M | $8M | $54M | $74M | $43M | $63M | $74M | $25M | $54M | $65M | $46M | $34M | |
| Net income | $93M | -$51M | $216M | $99M | $193M | $186M | $332M | $80M | $157M | $187M | $163M | $170M | |
| EPS (basic) | $0.75 | -$0.41 | $1.74 | $0.80 | $1.56 | $1.51 | $2.70 | $0.65 | $1.29 | $1.54 | $1.34 | $1.39 | |
| EPS (diluted) | $0.75 | -$0.41 | $1.73 | $0.79 | $1.54 | $1.50 | $2.68 | $0.65 | $1.29 | $1.54 | $1.33 | $1.39 | |
| Shares (basic, weighted) | 124M | 124M | 124M | 124M | 124M | 123M | 123M | 123M | 122M | 121M | 122M | 122M | |
| Shares (diluted, weighted) | 125M | 124M | 125M | 125M | 125M | 124M | 124M | 123M | 122M | 122M | 122M | 122M | |
| Depreciation & amortization | $57M | $58M | $59M | $54M | $53M | $55M | $57M | $56M | $55M | $58M | $78M | $74M | |
| EBITDA | $219M | $38M | $355M | $252M | $312M | $332M | $489M | $186M | $295M | $341M | $346M | $333M |
| Income statement | Trend | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.97B | $6.12B | $6.21B | $6.72B | $7.34B | $7.11B | $7.39B | $7.09B | $7.1B | $6.72B | |
| Cost of revenue | $3.3B | $3.45B | $3.49B | $3.66B | $4.14B | $4.56B | $4.48B | $4.05B | $3.89B | $3.88B | |
| Gross profit | $2.67B | $2.68B | $2.73B | $3.06B | $3.2B | $2.55B | $2.91B | $3.05B | $3.21B | $2.84B | |
| Research & development | $135M | $132M | $136M | $145M | $149M | $132M | $138M | $126M | $121M | $116M | |
| Sales & marketing | $599M | $570M | $612M | $675M | $790M | $709M | $734M | $832M | $770M | $749M | |
| General & administrative | $810M | $837M | $856M | $969M | $1B | $954M | $1.18B | $1.34B | $1.12B | $317M | |
| Other operating expenses | $10M | $11M | $17M | $13M | $31M | $31M | $30M | $29M | $21M | $0 | |
| Operating expenses | $1.55B | $1.55B | $1.62B | $1.8B | $1.97B | $1.83B | $2.09B | $2.33B | $2.04B | $1.18B | |
| Operating income | $1.12B | $1.13B | $1.11B | $1.26B | $1.23B | $719M | $823M | $723M | $1.18B | $1.66B | |
| Interest income | $4M | $6M | $3M | $2M | $5M | $5M | $16M | $23M | $9M | $8M | |
| Interest expense | $88M | $85M | $97M | $99M | $99M | $106M | $90M | $90M | $88M | $130M | |
| Other non-operating income (gains on investments, FX ...) | -$4M | -$14M | -$14M | -$23M | $226M | $6M | $495M | $235M | $11M | $741M | |
| Total non-operating income | -$84M | -$71M | -$83M | -$76M | -$325M | -$112M | -$585M | -$325M | -$99M | -$871M | |
| Income before tax | $1.03B | $1.05B | $1.02B | $1.19B | $900M | $607M | $238M | $398M | $1.08B | $791M | |
| Income tax | $330M | $231M | $204M | $246M | $181M | $136M | $77M | $106M | $254M | $190M | |
| Net income | $701M | $823M | $820M | $939M | $710M | $462M | $149M | $280M | $810M | $587M | |
| EPS (basic) | $5.43 | $6.37 | $6.42 | $7.46 | $5.65 | $3.75 | $1.21 | $2.25 | $6.56 | $4.82 | |
| EPS (diluted) | $5.33 | $6.25 | $6.32 | $7.35 | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 | $4.81 | |
| Shares (basic, weighted) | 129M | 129M | 128M | 126M | 126M | 123M | 124M | 124M | 124M | 122M | |
| Shares (diluted, weighted) | 132M | 132M | 130M | 128M | 127M | 124M | 124M | 125M | 124M | 122M | |
| Depreciation & amortization | $163M | $166M | $180M | $180M | $211M | $224M | $236M | $235M | $219M | $247M | |
| EBITDA | $1.28B | $1.31B | $1.3B | $1.46B | $1.21B | $937M | $564M | $723M | $1.39B | $1.17B |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-K 2026-06-30, 10-Q 2026-03-31, 10-Q 2025-12-31, 10-Q 2025-09-30, 10-K 2025-06-30, 10-Q 2025-03-31, 10-Q 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-12